Does PERTUZUMAB Cause Recurrent cancer? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Recurrent cancer have been filed in association with PERTUZUMAB (PERJETA). This represents 0.2% of all adverse event reports for PERTUZUMAB.
53
Reports of Recurrent cancer with PERTUZUMAB
0.2%
of all PERTUZUMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Recurrent cancer From PERTUZUMAB?
Of the 53 reports, 1 (1.9%) resulted in death, 11 (20.8%) required hospitalization.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PERTUZUMAB. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does PERTUZUMAB Cause?
Diarrhoea (3,343)
Off label use (1,886)
Fatigue (1,672)
Nausea (1,669)
Myelosuppression (1,311)
Disease progression (1,142)
Vomiting (1,096)
Dyspnoea (987)
Neuropathy peripheral (983)
Pyrexia (926)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
IMATINIB (237)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
Which PERTUZUMAB Alternatives Have Lower Recurrent cancer Risk?
PERTUZUMAB vs PERTUZUMAB\TRASTUZUMAB
PERTUZUMAB vs PETROLATUM
PERTUZUMAB vs PEVONEDISTAT
PERTUZUMAB vs PEXIDARTINIB
PERTUZUMAB vs PHENACETIN